+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Immunomodulators Market - Global Forecast 2025-2030- Product Image
Veterinary Immunomodulators Market - Global Forecast 2025-2030- Product Image
Sale

Veterinary Immunomodulators Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129190
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The veterinary immunomodulator market is advancing through notable scientific, regulatory, and industry changes, as senior leaders seek solutions that maximize animal welfare, address disease prevention, and support sustainable agricultural goals. In this dynamic context, carefully navigating evolving policy frameworks and emerging therapeutic options is essential for effective decision-making.

Market Snapshot: Veterinary Immunomodulators

The veterinary immunomodulator market is at a pivotal inflection, propelled by increasing adoption of advanced biotechnologies, heightened animal welfare considerations, and expanding therapeutic applications across diverse animal populations. Strategic investments in biologics and synthetic modulators are streamlining disease management and prevention, while evolving regulatory frameworks ensure robust, safe market expansion. Key stakeholders are leveraging innovation, collaborative partnerships, and digital tools to meet rising global demand for targeted immunomodulatory products and improve overall treatment efficacy.

Scope & Segmentation: Veterinary Immunomodulators Market

  • Product Types: Cytokines (Colony Stimulating Factors, Interferons, Interleukins, Tumor Necrosis Factors), Immunostimulants (Bacterial Derivatives, Plant Extracts), Monoclonal Antibodies (Chimeric, Fully Human, Humanized, Murine), Toll Like Receptor Agonists, Vaccines (Conjugate, Inactivated, Live Attenuated, Recombinant, Subunit).
  • Animal Types: Aquaculture (Crustaceans, Fish, Mollusks), Companion Animals (Cats, Dogs), Livestock (Cattle, Poultry, Swine).
  • Applications: Prophylactic (Active Immunization, Passive Immunization), Therapeutic (Allergy Management, Autoimmune Disorders Treatment, Cancer Therapy, Infectious Diseases Treatment, Wound Healing).
  • Routes of Administration: Intramuscular, Intravenous, Oral, Subcutaneous.
  • End Users: Animal Research Laboratories, Pharmaceutical Companies, Veterinary Hospitals and Clinics.
  • Disease Indications: Allergies, Autoimmune Disorders, Cancer, Infectious Diseases.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including United Kingdom, Germany, France, Russia, UAE, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and additional countries).
  • Companies Profiled: Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Virbac S.A., Vetoquinol S.A., HIPRA, S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC.

Key Takeaways for Decision-Makers

  • Biotechnology advancements are driving the next wave of veterinary immunomodulator development, enabling precise immune modulation and expanding the landscape of available therapies.
  • Senior leaders are prioritizing integration of real-world evidence and cross-sector collaboration to accelerate product innovation and streamline clinical trial processes.
  • Regional disparities, such as mature western infrastructure and rapid Asia-Pacific industrialization, require adaptive strategies and differentiated market approaches.
  • Supply chain resilience is a strategic focus, with investment in localized manufacturing, vertical integration, and modular production models supporting consistent product delivery and margin protection.
  • Portfolio diversification, through research alliances and acquisitions, supports responsiveness to evolving disease threats and expands access to cutting-edge immunomodulatory therapies.
  • Industry players adopting digital health solutions and advanced analytics are enhancing pharmacovigilance, optimizing inventory practices, and strengthening value propositions for end users.

Tariff Impact: 2025 United States Policy Changes

New tariffs on components and finished products in 2025 are reorganizing global supply chains. Companies are revisiting sourcing strategies, prioritizing domestic suppliers, and investing in alternative biologic platforms. Cost structures are shifting, and firms with agile procurement practices are gaining a relative competitive advantage.

Methodology & Data Sources

This report applies a multifaceted methodology, combining structured interviews with senior animal health executives, practitioners, and manufacturing specialists with analysis of peer-reviewed publications, regulatory documents, and proprietary market databases. Quantitative scenario modeling and rigorous triangulation underpin all findings, ensuring insight depth and robust data integrity.

Why This Report Matters

  • Enables informed strategic planning by clarifying how biotechnological innovation, regulatory shifts, and global market factors affect immunomodulator adoption.
  • Empowers senior decision-makers with actionable segmentation insights and competitor profiles tailored to today’s rapidly changing animal health sector.
  • Highlights operational and partnership opportunities that support continuity, sustainability, and market resilience in the evolving landscape.

Conclusion

Forward-thinking organizations that embed collaboration, evidence-based innovation, and regulatory engagement stand to capture new value in veterinary immunomodulators. With the right strategies, market leaders can drive superior outcomes and bolster their positions as animal health paradigms shift.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of nanoparticle-based delivery systems for enhanced veterinary immunomodulator efficacy
5.2. Expansion of companion animal biologic immunotherapies targeting chronic inflammatory conditions in dogs
5.3. Regulatory harmonization efforts to streamline approval processes for novel veterinary immunomodulators
5.4. Integration of precision livestock farming technologies with immunomodulator treatment monitoring systems
5.5. Increasing investment in plant-derived immunomodulators for equine respiratory and musculoskeletal health
5.6. Advancements in aquaculture immunomodulator formulations to reduce antibiotic reliance in fish farming
5.7. Development of personalized immunomodulator dosing protocols informed by veterinary pharmacogenomics data sets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Immunomodulators Market, by Product Type
8.1. Introduction
8.2. Cytokines
8.2.1. Colony Stimulating Factors
8.2.2. Interferons
8.2.3. Interleukins
8.2.4. Tumor Necrosis Factors
8.3. Immunostimulants
8.3.1. Bacterial Derivatives
8.3.2. Plant Extracts
8.4. Monoclonal Antibodies
8.4.1. Chimeric
8.4.2. Fully Human
8.4.3. Humanized
8.4.4. Murine
8.5. Toll Like Receptor Agonists
8.6. Vaccines
8.6.1. Conjugate
8.6.2. Inactivated
8.6.3. Live Attenuated
8.6.4. Recombinant
8.6.5. Subunit
9. Veterinary Immunomodulators Market, by Animal Type
9.1. Introduction
9.2. Aquaculture
9.2.1. Crustaceans
9.2.2. Fish
9.2.3. Mollusks
9.3. Companion Animals
9.3.1. Cats
9.3.2. Dogs
9.4. Livestock
9.4.1. Cattle
9.4.2. Poultry
9.4.3. Swine
10. Veterinary Immunomodulators Market, by Application
10.1. Introduction
10.2. Prophylactic
10.2.1. Active Immunization
10.2.2. Passive Immunization
10.3. Therapeutic
10.3.1. Allergy Management
10.3.2. Autoimmune Disorders Treatment
10.3.3. Cancer Therapy
10.3.4. Infectious Diseases Treatment
10.3.5. Wound Healing
11. Veterinary Immunomodulators Market, by Route Of Administration
11.1. Introduction
11.2. Intramuscular
11.3. Intravenous
11.4. Oral
11.5. Subcutaneous
12. Veterinary Immunomodulators Market, by End User
12.1. Introduction
12.2. Animal Research Laboratories
12.3. Pharmaceutical Companies
12.4. Veterinary Hospitals Clinics
13. Veterinary Immunomodulators Market, by Disease Indication
13.1. Introduction
13.2. Allergies
13.3. Autoimmune Disorders
13.4. Cancer
13.5. Infectious Diseases
14. Americas Veterinary Immunomodulators Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Veterinary Immunomodulators Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Veterinary Immunomodulators Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Merck & Co., Inc.
17.3.3. Elanco Animal Health Incorporated
17.3.4. Boehringer Ingelheim International GmbH
17.3.5. Ceva Santé Animale
17.3.6. Virbac S.A.
17.3.7. Vetoquinol S.A.
17.3.8. HIPRA, S.A.
17.3.9. Phibro Animal Health Corporation
17.3.10. Dechra Pharmaceuticals PLC
18. ResearchAI19. ResearchStatistics20. ResearchContacts21. ResearchArticles22. Appendix
List of Figures
FIGURE 1. VETERINARY IMMUNOMODULATORS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. VETERINARY IMMUNOMODULATORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. VETERINARY IMMUNOMODULATORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. VETERINARY IMMUNOMODULATORS MARKET: RESEARCHAI
FIGURE 28. VETERINARY IMMUNOMODULATORS MARKET: RESEARCHSTATISTICS
FIGURE 29. VETERINARY IMMUNOMODULATORS MARKET: RESEARCHCONTACTS
FIGURE 30. VETERINARY IMMUNOMODULATORS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VETERINARY IMMUNOMODULATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COLONY STIMULATING FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COLONY STIMULATING FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTERFERONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTERLEUKINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTERLEUKINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY TUMOR NECROSIS FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY TUMOR NECROSIS FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY BACTERIAL DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY BACTERIAL DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CHIMERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY HUMANIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MURINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MURINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY TOLL LIKE RECEPTOR AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY TOLL LIKE RECEPTOR AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CONJUGATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CONJUGATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CRUSTACEANS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CRUSTACEANS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY FISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MOLLUSKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MOLLUSKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ACTIVE IMMUNIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ACTIVE IMMUNIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PASSIVE IMMUNIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PASSIVE IMMUNIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ALLERGY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ALLERGY MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AUTOIMMUNE DISORDERS TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AUTOIMMUNE DISORDERS TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CANCER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INFECTIOUS DISEASES TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INFECTIOUS DISEASES TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VETERINARY HOSPITALS CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VETERINARY HOSPITALS CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ALLERGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES VETERINARY IMMUNOMODULATORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 205. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2018-2024 (USD MILLION)
TABLE 208. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2025-2030 (USD MILLION)
TABLE 209. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 210. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 211. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 212. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 213. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 214. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 215. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 216. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 217. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 218. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 219. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 220. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 221. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 222. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 223. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2018-2024 (USD MILLION)
TABLE 226. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2025-2030 (USD MILLION)
TABLE 227. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 228. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 229. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 234. CANADA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 235. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2018-2024 (USD MILLION)
TABLE 238. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2025-2030 (USD MILLION)
TABLE 239. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 242. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 243. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 244. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 245. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 252. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 253. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2018-2024 (USD MILLION)
TABLE 256. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2025-2030 (USD MILLION)
TABLE 257. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 258. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 259. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 264. MEXICO VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PROPHYLACTIC, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL VETERINARY IMMUNOMODULATORS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY CYTOKINES, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA VETERINARY IMMUNOMODULATORS MARKET SIZE, BY LIVES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Veterinary Immunomodulators Market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC

Related Topics

Related Reports

Immunomodulators Market - Global Forecast 2025-2030 - Product Image

Immunomodulators Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Food Immunomodulator Market - Global Forecast 2025-2030 - Product Image

Food Immunomodulator Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Immunomodulators - Global Strategic Business Report - Product Image

Immunomodulators - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Immunomodulator Market Report 2025 - Product Image

Immunomodulator Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Immunomodulator Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Immunomodulator Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.